Evidence map›Paper›PMID 9542961›Full record

ArticleJournal of clinical microbiology1998

Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans.

J Merlino, E Tambosis, D Veal

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Prevalence and drug susceptibility of clinicalOne health (Amsterdam, Netherlands) · 2024
    Article
  2. Assessing Diagnosis ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Candida parapsilosis : an emerging fungal pathogen.The Indian journal of medical research · 2012
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J MerlinoDepartment of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, New South Wales, Australia. john@micr.crg.cs.nsw.gov.au
E Tambosis
D Veal

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes a new, modified, simple, and cost-effective method for the use of CHROMagar Candida (CHROMagar Company, Paris, France) for the presumptive identification of isolates as Candida albicans after preliminary growth. Sixty randomly selected clinical isolates were evaluated, including 38 of C. albicans. With incubation at 37 degrees C for 24 h, the sensitivity and specificity appeared to be excellent and the test performed better than the traditional germ tube test. However, at earlier times, C. tropicalis isolates gave false-positive results.

Indexed as

Candida albicansChromogenic CompoundsCulture MediaHumansChromogenic CompoundsCulture Media

Identifiers

PMID9542961
PMCPMC104713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.